For research use only. Not for human consumption.
GLP-1 is an endogenous incretin peptide hormone naturally synthesized by intestinal L-cells in response to nutrient ingestion.
Price range: $50.00 through $80.00
GLP-1 is an endogenous incretin peptide hormone naturally synthesized by intestinal L-cells in response to nutrient ingestion. It plays a foundational role in metabolic regulation by activating GLP-1 receptors in pancreatic $beta$-cells, the central nervous system, and the gastrointestinal tract to modulate glucose homeostasis and energy balance.
Glucose-Dependent Insulin Secretion: Studied for its ability to stimulate insulin release from pancreatic cells exclusively in the presence of elevated blood glucose levels.
Central Appetite & Gastric Motility: Evaluated for delaying gastric emptying rate and activating hypothalamic signaling pathways to induce satiety.
Glucagon Suppression & Glycemic Control: Researched for downregulating inappropriate postprandial glucagon secretion, aiding hepatic glucose clearance.
To provide a baseline incretin peptide compound for investigating receptor binding affinity, glucose-dependent insulinotropic signaling, appetite regulation, and metabolic homeostasis in laboratory research.
| Property | Details |
| Product Name | GLP-1 (Glucagon-Like Peptide-1) |
| Product Category | Incretin Hormones & Metabolic Peptides |
| Compound Type | Endogenous Incretin Peptide Hormone |
| Primary Goal | Insulinotropic signaling, gastric motility delay, and glycemic control study |
| Form | Lyophilized powder (vial) |
| Storage | Store lyophilized powder at 2°C to 8°C (refrigerated) or -20°C for long-term storage. Protect from direct light. |
| Intended Use | Laboratory Research Only |
| Dosage | 10MG, 20MG |
|---|
Explore similar research-grade peptides, selected to complement your research needs.
By proceeding you affirm the statements above are true. This site uses cookies to remember your verification status. Privacy Policy.
